1. Chromosomes and Gene Expression
  2. Neuroscience

GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis

  1. Markus Terrey
  2. Scott I Adamson
  3. Alana L Gibson
  4. Tianda Deng
  5. Ryuta Ishimura
  6. Jeffrey H Chuang
  7. Susan L Ackerman  Is a corresponding author
  1. Howard Hughes Medical Institute, Department of Cellular and Molecular Medicine, Section of Neurobiology, Division of Biological Sciences, University of California, San Diego, United States
  2. Graduate School of Biomedical Sciences and Engineering, University of Maine, United States
  3. The Jackson Laboratory for Genomic Medicine, United States
  4. Department of Genetics and Genome Sciences, Institute for Systems Genomics, UConn Health, United States
  5. Division of Biological Sciences, Section of Molecular Biology, University of California, San Diego, United States
  6. The Jackson Laboratory for Mammalian Genetics, United States
https://doi.org/10.7554/eLife.62731
Share this article
Cite this article
  1. Markus Terrey
  2. Scott I Adamson
  3. Alana L Gibson
  4. Tianda Deng
  5. Ryuta Ishimura
  6. Jeffrey H Chuang
  7. Susan L Ackerman
(2020)
GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis
eLife 9:e62731.
https://doi.org/10.7554/eLife.62731
  2. Download BibTeX
  3. Download .RIS

Abstract

Ribosome-associated quality control pathways respond to defects in translational elongation to recycle arrested ribosomes and degrade aberrant polypeptides and mRNAs. Loss of a tRNA gene leads to ribosomal pausing that is resolved by the translational GTPase GTPBP2, and in its absence causes neuron death. Here, we show that loss of the homologous protein GTPBP1 during tRNA deficiency in the mouse brain also leads to codon-specific ribosome pausing and neurodegeneration, suggesting that these non-redundant GTPases function in the same pathway to mitigate ribosome pausing. As observed in Gtpbp2-/- mice (Ishimura et al., 2016), GCN2-mediated activation of the integrated stress response (ISR) was apparent in the Gtpbp1-/- brain. We observed decreased mTORC1 signaling which increased neuronal death, whereas ISR activation was neuroprotective. Our data demonstrate that GTPBP1 functions as an important quality control mechanism during translation elongation and suggest that translational signaling pathways intricately interact to regulate neuronal homeostasis during defective elongation.

Introduction

Translation of mRNA into protein utilizes four principle cycles: translation initiation, elongation, termination and ribosome recycling (Schuller and Green, 2018). During translation initiation, eukaryotic translation initiation factors (eIFs) mediate assembly of an 80S ribosome and an initiator methionyl-tRNA at the start codon. Subsequently, the elongating 80S ribosome moves along the mRNA decoding mRNA triplets until the termination codon is reached where eukaryotic peptide chain release factors (eRFs) stimulate the release of the nascent protein. Lastly, to permit engagement of ribosomes in new rounds of translation, the terminated 80S ribosome complex is separated into the 40S and 60S subunits and released from the mRNA by ATP-binding cassette sub-family E member 1 (ABCE1).

Although much attention has been dedicated to the regulation of protein synthesis through translation initiation, collective evidence highlights the effect of translation elongation and its kinetics on protein synthesis (Stein and Frydman, 2019). Elongation rates not only vary between mRNAs generated from different genes but rates also fluctuate across a given transcript (Chaney and Clark, 2015; Kaiser and Liu, 2018; Rodnina, 2016). Multiple factors including secondary structure of mRNAs, availability of tRNAs, interactions of the nascent peptide with the ribosome and codon identity influence elongation rates, and variations in these rates affect co-translational protein folding, translational fidelity, and gene expression through mRNA decay (Brule and Grayhack, 2017; Buhr et al., 2016; Chaney and Clark, 2015; Drummond and Wilke, 2008; Rodnina, 2016; Spencer et al., 2012; Thommen et al., 2017; Wolf and Grayhack, 2015; Yu et al., 2015).

With growing evidence suggesting translation elongation is regulated, elaborate mRNA surveillance mechanisms that resolve translation elongation defects have been identified (Brandman and Hegde, 2016; Joazeiro, 2019). We previously reported that an ENU-induced null mutation (nmf205) in the translational GTPase (trGTPase) GTPBP2 causes early, widespread neurodegeneration when present on the common inbred mouse strain C57BL/6J (B6J) (Ishimura et al., 2014). Neuron death in B6J-Gtpbp2nmf205/nmf205 (B6J-Gtpbp2-/-) mice is a result of the epistatic interaction between the null mutation in Gtpbp2 and a hypomorphic mutation present in the B6J strain that disrupts processing of the brain-specific, nuclear encoded tRNA, n-Tr20. n-Tr20 is widely expressed in neurons and is the most highly expressed of the five tRNAArgUCU genes in the brain, and the B6J-associated mutation reduces the pool of available tRNAArgUCU (Ishimura et al., 2014; Kapur et al., 2020). In the absence of Gtpbp2, translating ribosomes in the cerebellum exhibit prolonged pauses at AGA codons, suggesting GTPBP2 acts as a ribosome-rescue factor to resolve codon-specific ribosome pausing that occurs when the available pool of cognate tRNAs is limited. The essential role of Gtpbp2 in neuronal homeostasis was further revealed by the identification of mutations in Gtpbp2 causing neurological defects and intellectual disabilities in humans (Bertoli-Avella et al., 2018; Carter et al., 2019; Jaberi et al., 2016).

Defects in translation elongation may feedback to regulate translation initiation, supporting the emerging link between translation elongation and initiation to control global translation (Chu et al., 2014; Inglis et al., 2019; Liakath-Ali et al., 2018; Sanchez et al., 2019). Translation is highly regulated by two signaling pathways: the mTOR signaling pathway and the integrated stress response (ISR). mTOR complex 1 (mTORC1) phosphorylates the ribosomal protein S6 kinase (S6K1) and the eIF4E binding protein 1 (4E-BP1) to positively regulate translation initiation and elongation (Nandagopal and Roux, 2015; Thoreen, 2017). The ISR reprograms the translatome by inhibiting translation initiation to suppress global translation via phosphorylation of the translation initiation factor eIF2α (p-eIF2αS51) which inhibits formation of the ternary complex, while allowing translation of stress-responsive genes such as ATF4 (Harding et al., 2003; Wortel et al., 2017). In the B6J-Gtpbp2-/- cerebellum, ribosome stalling is accompanied by induction of the ISR (Ishimura et al., 2014). Phosphorylation of eIF2α in the B6J-Gtpbp2-/- cerebellum is mediated by GCN2, one of four known kinases in mammals (Dalton et al., 2012), which are activated during distinct cellular or environmental stressors. Deletion of Gcn2 in B6J-Gtpbp2-/- mice led to increased neurodegeneration, demonstrating GCN2-dependent activation of the ISR acts to partially restore cellular homeostasis (Chesnokova et al., 2017; Dalton et al., 2012; Ishimura et al., 2016).

In addition to Gtpbp2, the genome of many eukaryotes contains a related gene, Gtpbp1 (Atkinson, 2015). A previous report demonstrated that loss of Gtpbp1 in mice did not lead to overt defects, suggesting functional redundancy between Gtpbp1 and Gtpbp2 (Senju et al., 2000). However, here we demonstrate that loss of Gtpbp1 in mice with the B6J-associated mutation in n-Tr20 causes neurodegeneration identical to that observed in B6J-Gtpbp2-/- mice. Furthermore, ribosome footprint profiling analysis suggests GTPBP1 functions as a novel ribosome-rescue factor to resolve ribosome pausing defects during tRNA deficiency. As observed in B6J-Gtpbp2-/- mice, the ISR is also induced in the B6J.Gtpbp1-/- brain and protects neurons from ribosome-pausing induced neurodegeneration. Finally, we show that deficiencies in ribosome pause resolution alter mTOR signaling in a cell type-specific manner, suggesting that differences in the modulation of translational signaling pathways may contribute to the selective neurodegeneration observed with defects in translation elongation.

Results

Loss of Gtpbp1 leads to widespread neurodegeneration when tRNA is deficient

Previously we demonstrated that loss of the trGTPase GTPBP2 causes progressive neurodegeneration in mice (Ishimura et al., 2014). However, mice homozygous for a null mutation in Gtpbp1, which encodes a structurally related trGTPase (Figure 1A), were reported to have no apparent phenotypes on a mixed genetic background (Senju et al., 2000). Both GTPBP2 and GTPBP1 are expressed in many tissues, and in situ hybridization revealed that transcripts of these genes were widely expressed throughout the brain (Ishimura et al., 2014; Senju et al., 2000; Figure 1B–D, Figure 1—figure supplement 1A and B). Interestingly, expression of Gtpbp1 and Gtpbp2 occurred both in neurons that degenerate in Gtpbp2-/- mice (e.g. cerebellar granule cells, dentate gyrus (DG) granule cells, neurons in cortical layer IV) and those that do not (e.g. hippocampal pyramidal cells and non-layer IV cortical neurons) suggesting possible functional redundancy between these genes in some cell types.

Figure 1 with 2 supplements see all
Download asset Open asset
tRNA deficiency induces neurodegeneration in B6J.Gtpbp1-/- mice.

(A) Domain structure of mouse GTPBP2 and GTPBP1. The percent of identical amino acids for each domain is shown. (B–D) In situ hybridization demonstrating ubiquitous expression of Gtpbp1 (yellow) and Gtpbp2 (red) in the P28 wild type (B6J) cerebellum (B), and CA1 region of the hippocampus (C), dentate gyrus (DG) (D) (n = 2 mice). Images of individual probes from areas defined by rectangles in C and D are shown above merged images. (E, F) Hematoxylin and eosin staining of sagittal sections of the cerebellum (n = 3–4 mice/genotype). Higher magnification images of lobule IX are shown below each genotype. Cerebellar lobes are indicated by Roman numerals. (G, H) Number of cerebellar granule cells in lobule VI (G) and lobule IX (H) of 3-, 4-, and 6-week-old BP1 (B6J.Gtpbp1-/-); BP2 (B6J-Gtpbp2-/-); and BP1, BP2 (B6J.Gtpbp1-/-; Gtpbp2-/-) mice (n = 3 mice/genotype). Data represent mean + SD. ML, molecular cell layer; PL, Purkinje cell layer; GCL, granule cell layer. Scale bars: 20 μm (B, C, D); 500 μm and 50 μm (higher magnification) (E, F). One-way ANOVA was corrected for multiple comparisons using Tukey method (G, H). ***p≤0.001, ****p≤0.0001.

Figure 1—source data 1

tRNA deficiency induces neurodegeneration in B6J.Gtpbp1-/- mice.

https://cdn.elifesciences.org/articles/62731/elife-62731-fig1-data1-v2.xlsx

To investigate if phenotypes in Gtpbp1-/- mice are dependent on genetic background as observed for B6J-Gtpbp2-/- mice, we generated congenic B6J.Gtpbp1-/- mice. Like B6J-Gtpbp2-/- mice, B6J.Gtpbp1-/- mice were indistinguishable from littermate controls at 3 weeks of age, developed overt ataxia by 6 weeks, and died by 8 weeks of age. Cerebellar degeneration was also similar to that observed in B6J-Gtpbp2-/- mice (Ishimura et al., 2014; Figure 1E). Apoptotic granule cells were observed in caudal lobes of the cerebellum just prior to 4 weeks of age and these neurons progressively died in a posterior to anterior manner. As previously observed in B6J-Gtpbp2-/- mice, granule cells in the DG, layer IV cortical neurons and multiple neurons in the retina degenerated in B6J.Gtpbp1-/- mice, but cell death was not observed for other neurons such as hippocampal pyramidal cells or neurons in the other layers of the cortex (Figure 1—figure supplement 2A–E). Consistent with the dependency of cerebellar granule cell degeneration on levels of n-Tr20, a tRNAArgUCU gene with a processing mutation in the B6J strain, transgenic expression of wild type n-Tr20 greatly attenuated degeneration of these neurons as has previously been observed for B6J-Gtpbp2-/- mice (Figure 1E).

To genetically test for compensation between Gtpbp1 and Gtpbp2, we analyzed mice that had mutations in both genes. Neurodegeneration was not observed in mice heterozygous for mutations in both Gtpbp1 and Gtpbp2 (Figure 1F). Furthermore, the onset, progression and specificity of neurodegeneration were similar between B6J.Gtpbp1-/-; Gtpbp2-/-, B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice (Figure 1F–H). These results suggest that Gtpbp1 and Gtpbp2 are functionally distinct and act in a common pathway to mediate cellular homeostasis that is necessary for neuron survival.

GTPBP1 is a novel ribosome-rescue factor

The genetic interaction between the B6J-derived n-Tr20 mutation and the loss of Gtpbp1 suggested that like GTPBP2, GTPBP1 might act as a rescue factor for ribosomes paused at AGA codons. To investigate this possibility, we performed ribosome profiling on cerebella from 3-week-old B6J.Gtpbp1-/- and B6J mice. As previously observed in the B6J-Gtpbp2-/- cerebellum, ribosome occupancy dramatically increased in the B6J-Gtpbp1-/- cerebellum when AGA codons were in the A-site of the ribosome (Figure 2A and B, Figure 2—figure supplement 1A). Comparison of genes with AGA pauses revealed that approximately 50% of pausing genes were shared between libraries generated from individual B6J.Gtpbp1-/- mice, and this was also true for B6J-Gtpbp2-/- mice, supporting that AGA pausing is likely stochastic (Figure 2C). Similarly, about 50% of genes with AGA pausing intersected between B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice (Figure 2—figure supplement 1B, Supplementary file 1). Consistent with stochastic pausing at AGA codons, gene ontology (GO) analysis of genes with pauses revealed enrichment in numerous biological processes and the majority of these processes were enriched in both Gtpbp1 and Gtpbp2 (Figure 2—figure supplement 1C). Thus, our data suggest that both GTPBP1 and GTPBP2 rescue stochastic ribosome-pausing events when the tRNAArgUCU pool is reduced.

Figure 2 with 1 supplement see all
Download asset Open asset
GTPBP1 resolves ribosome pausing induced by tRNA deficiency.

(A) Ribosome occupancy was calculated by dividing the number of genome-wide reads at codons by the expected reads in the ribosomal A-site (n = 3 biological replicates). Data represent mean + SEM. Note that ribosome occupancy increased only at AGA codons in P21 B6J.Gtpbp1-/- mice. (B) Ribosome occupancy at AGA codons was calculated by dividing genome-wide reads at AGA codons by expected reads. Data represent mean + SEM from ribosome profiling from cerebella of P21 B6J and B6J.Gtpbp1-/- mice (n = 3 biological replicates). (C) Venn diagram of genes with increased ribosome occupancy at AGA codons (z-score ≥10) between libraries prepared from individual B6J.Gtpbp1-/- (red) or B6J-Gtpbp2-/- (blue) mice (biological replicates 1–3). (D) Significant (q-value ≤0.05, q-value refers to the corrected p-value using Benjamini-Hochberg correction) transcriptional changes in gene expression between P21 B6J and B6J.Gtpbp1-/- cerebellum (x-axis, DE Gtpbp1) are plotted against those between P21 B6J and B6J-Gtpbp2-/- cerebellum (y-axis, DE Gtpbp2) (n = 3 biological replicates). Significant (q-value ≤0.05) Gtpbp1-dependent expression changes are colored in pink and Gtpbp2-dependent expression changes in blue. Significant (q-value ≤0.05) transcriptional changes in gene expression between B6J.Gtpbp1-/- and B6J-Gtpbp2-/- are shown in red (27 genes). The beta effect size is analogous to the natural log fold change in expression. (E) Analysis of differential gene expression between P21 B6J and B6J.Gtpbp1-/- mice (DE Gtpbp1). Significant (q-value ≤0.05) transcriptional changes in gene expression are shown in grey, and genes with increased AGA ribosome occupancy (z-score ≥10, detected in at least two biological replicates) that are differentially expressed are highlighted in red (260 genes). The beta effect size is analogous to the natural log fold change in expression and 1.5-fold changes in gene expression are indicated by the red dashed lines. Multiple t tests were corrected for multiple comparisons using Holm-Sidak method (B). **p≤0.01.

Figure 2—source data 1

GTPBP1 resolves ribosome pausing induced by tRNA deficiency.

https://cdn.elifesciences.org/articles/62731/elife-62731-fig2-data1-v2.xlsx

To determine if transcriptional changes are shared upon loss of Gtpbp1 and Gtpbp2, we performed RNA-sequencing analysis. Comparison of data from the cerebellum of 3-week-old B6J.Gtpbp1-/- and B6J mice revealed significant (q-value ≤0.05) differential expression (DE) of approximately 12% of the detected genes, with 46% upregulated and 54% downregulated (DE Gtpbp1, Supplementary file 2). Similarly, loss of Gtpbp2 altered expression of about 10% of the detected genes with 45% and 55% upregulated and downregulated, respectively, when compared to B6J (DE Gtpbp2, Supplementary file 2). Interestingly, only 27 genes (mostly non-coding genes) were differentially expressed between Gtpbp1-/- and Gtpbp2-/- cerebella, revealing that loss of either gene similarly altered the transcriptome (Figure 2D, Supplementary file 2).

The high similarity of gene expression changes in Gtpbp1 and Gtpbp2 mutant mice, combined with our observation that ribosome-pausing defects are likely stochastic, suggested that transcriptional alterations might reflect a common cellular response to ribosome pausing rather than changes in levels of the specific genes that harbor paused ribosomes. In agreement, transcriptional changes were only weakly correlated with genes showing increased ribosomal occupancy (Spearman correlation coefficient of 0.0405, p-value=0.0083). Significant (q-value ≤0.05) changes in expression were only observed in 33% or 26% of the genes with AGA pauses (that were detected in at least two replicates) in the Gtpbp1-/- and Gtpbp2-/- cerebellum, respectively (Figure 2E).

Loss of GTPBP1 activates the ISR

In order to identify molecular pathways that might respond to ribosome pausing, we performed upstream regulator analysis (Ingenuity Pathway Analysis) of genes differentially expressed between B6J and B6J.Gtpbp1-/- mice (DE Gtpbp1). This analysis revealed significant enrichment for activation of the transcription factor ATF4, an effector of the ISR (Figure 3A, inset). The ISR is induced by the coupling of stress signals to the phosphorylation of serine 51 of the translation initiation factor eIF2α to decrease translation initiation. While the ISR reduces translation of many mRNAs, translation of ATF4 is enhanced, which results in the upregulation of genes to restore cellular homeostasis. We previously observed induction of the ISR in the B6J-Gtpbp2-/- cerebellum suggesting that activation of this pathway may be a common cellular response to ribosome stalling (Ishimura et al., 2016). In agreement, Atf4 and 141 of the 153 differentially expressed ATF4 target genes (Han et al., 2013) were upregulated in the cerebellum of 3-week-old B6J.Gtpbp1-/- mice (DE Gtpbp1, Figure 3A). Furthermore, levels of phosphorylated eIF2α (p-eIF2αS51) were increased in the cerebellum and hippocampus of B6J.Gtpbp1-/- mice (Figure 3B and C). In agreement, in situ hybridization of the B6J.Gtpbp1-/- hippocampus with probes to ATF4 targets induced in the cerebellum of these mice demonstrated that these ATF4 targets were also induced in hippocampal neurons of 3-week-old mutant mice (Figure 3D). Interestingly, induction of ATF4 targets varied in different types of neurons. Sesn2, Slc7a1, and Chac1 were upregulated in both CA1 and DG neurons, whereas Ddr2 was only upregulated in CA1 neurons (Figure 3D).

Figure 3 with 1 supplement see all
Download asset Open asset
Ribosome pausing activates the integrated stress response (ISR) to ameliorate neurodegeneration in Gtpbp1-/- mice.

(A) Analysis of transcriptional changes in gene expression between P21 B6J and B6J.Gtpbp1-/- mice (DE Gtpbp1) (n = 3 biological replicates). Significant (q-value ≤0.05, q-value refers to the corrected p-value using Benjamini-Hochberg correction) changes in expression are shown in grey and differentially expressed ATF4 targets are highlighted in green. The beta effect size is analogous to the natural log fold change in expression and 1.5-fold changes in gene expression are indicated (red dashed lines). (Inset) Identification of upstream regulators using Ingenuity Pathway Analysis (IPA) of differentially expressed genes between B6J and B6J.Gtpbp1-/- mice (DE Gtpbp1). Top ten transcription factors and kinases (italics) are shown. (B) Western blot analysis of tissue lysates from P21 mice. Vinculin was used as an input control. (C) Relative abundance of p-eIF2αS51 and p-S6S240/244 in the hippocampus and cerebellum of BP1 (B6J.Gtpbp1-/-), BP2 (B6J-Gtpbp2-/-), and control (B6J) mice (n = 3 mice/genotype). Levels of p-eIF2αS51 or p-S6S240/244 were normalized to total level of eIF2α or S6, and phosphorylation levels are relative to those of B6J. Data represent mean + SD. (D) In situ hybridization of ATF4 targets in the hippocampal CA1 and dentate gyrus (DG) at P21 (n = 3 mice/genotype). (E) Sagittal cerebellar sections stained with hematoxylin and eosin. Higher magnification images of lobule IX are shown below each genotype (n = 3 mice/genotype). Cerebellar lobes are indicated by Roman numerals. (F) Quantification of cerebellar granule cells of lobule VI and lobule IX of control (B6J), BP1 (B6J.Gtpbp1-/-), and Gcn2; BP1 (B6J.Gcn2-/-; Gtpbp1-/-) mice at P35 (n = 3 mice/genotype). Data represent mean + SD. (G) Percent of DG and CA1 neurons that are pyknotic in control (B6J), BP1 (B6J.Gtpbp1-/-), and Gcn2; BP1 (B6J.Gcn2-/-; Gtpbp1-/-) mice at P35 (n = 3 mice/genotype). Data represent mean + SD. (H) Sagittal sections of the CA1 area of the hippocampus stained with hematoxylin and eosin (n = 3 mice/genotype). Arrowheads indicate pyknotic cells. Scale bars: 50 μm (D); 500 μm and 50 μm (higher magnification) (E); 20 μm (H). One-way ANOVA was corrected for multiple comparisons using Tukey method (C, F, G). **p≤0.01, ***p≤0.001, ****p≤0.0001.

Figure 3—source data 1

Ribosome pausing activates theintegrated stress response (ISR) to ameliorate neurodegeneration in Gtpbp1-/- mice.

https://cdn.elifesciences.org/articles/62731/elife-62731-fig3-data1-v2.xlsx

In B6J-Gtpbp2-/- mice, the ISR is activated by the eIF2α kinase GCN2 (EIF2AK4). Inhibition of ISR activation via Gcn2 deletion in these mice accelerated cerebellar granule cell death and induced neurodegeneration of hippocampal pyramidal cells (Ishimura et al., 2016). GCN2 was enriched in upstream regulator analysis of differentially expressed genes in the B6J.Gtpbp1-/- cerebellum (DE Gtpbp1), suggesting that this kinase may also mediate activation of the ISR in Gtpbp1-deficient mice (Figure 3A, inset). In agreement, Gcn2 deletion in B6J.Gtpbp1-/- mice accelerated degeneration of cerebellar granule cells. In 5-week-old B6J.Gtpbp1-/-; Gcn2-/- mice, 65% of these neurons had degenerated compared to 37% in B6J.Gtpbp1-/- mice (Figure 3E and F). Furthermore, the DG of B6J.Gtpbp1-/-; Gcn2-/- mice had twice the number of granule cells with pyknotic nuclei compared to B6J.Gtpbp1-/- mice (Figure 3G, Figure 3—figure supplement 1). Finally, although CA1 pyramidal neurons do not normally degenerate in B6J.Gtpbp1-/- mice, 10.3% of these neurons were undergoing apoptosis in the hippocampus of 5-week-old B6J.Gtpbp1-/-; Gcn2-/- mice (Figure 3G and H). As previously reported (Ishimura et al., 2016; Zhang et al., 2002), neurodegeneration was not observed in the B6J.Gcn2-/- brain (data not shown).

Loss of Gtpbp1 or Gtpbp2 induces neuron-specific changes in mTOR signaling

Our data suggest that defects in translation elongation activate the ISR, which regulates translation initiation and influences neurodegeneration. Thus, we wondered if ribosome pausing in Gtpbp1 or Gtpbp2 mutant mice could alter additional translational control pathways. Upstream regulator analysis of differentially expressed genes in the cerebellum of B6J.Gtpbp1-/- mice (DE Gtpbp1) revealed enrichment, although lower than that observed for ATF4, of the mammalian target of rapamycin kinase (mTOR) (Figure 3A, inset). mTOR functions in two distinct protein complexes known as mTOR complex 1 (mTORC1) and complex 2 (mTORC2). Although association with membrane bound ribosomes (i.e. the endoplasmic reticulum) has been observed for mTORC2, the central role of mTOR in protein translation is largely attributed to mTORC1 through phosphorylation of specific effector proteins and translation of particular genes that contain 5’ terminal oligopyrimidine (TOP) tracts (Dai and Lu, 2009; Laplante and Sabatini, 2013; Laplante and Sabatini, 2009; Ma and Blenis, 2009a; Ma and Blenis, 2009b; Nandagopal and Roux, 2015; Zinzalla et al., 2011). To determine if mTOR activity is altered by loss of Gtpbp1 or Gtpbp2, we analyzed the translational efficiency (TE) (Supplementary file 3) of genes regulated by mTORC1 via their TOP motifs by normalizing the number of ribosome footprint reads to that of RNA-sequencing reads. In addition, we assessed the phosphorylation status of the ribosomal protein S6 (p-S6240/244), a known downstream target of mTORC1 (Saxton and Sabatini, 2017; Thoreen et al., 2012). Only one of the 53 detected 5’TOP genes had an altered TE in the B6J.Gtpbp1-/- cerebellum (Rps29, TE Gtpbp1) or in the B6J-Gtpbp2-/- cerebellum (Rplp0, TE Gtpbp2) compared to the B6J cerebellum (Supplementary file 3, Figure 4—figure supplement 1A). In addition, levels of p-S6240/244 were unchanged at 3 weeks of age in the cerebellum of both mutant strains, suggesting that mTOR signaling is not altered by ribosome pausing in granule cells, which comprise the vast majority of cells in the cerebellum (Figure 3B and C).

In contrast to the cerebellum, p-S6240/244 levels were decreased by about 90% in the hippocampus of 3-week-old B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice relative to wild type (Figure 3B and C). Interestingly, immunofluorescence using antibodies to p-S6240/244 revealed that the reduction of p-S6240/244 in the mutant hippocampus was more pronounced in specific neuron populations. In the control hippocampus, p-S6240/244 signal was most intense in CA3 pyramidal cells and lower in CA1 pyramidal cells and DG granule cells (Figure 4A). In B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mutant hippocampi, p-S6240/244 levels were dramatically reduced in the granule cells of the DG and some scattered CA1 neurons (Figure 4A). However, levels of p-S6240/244 were not affected in CA3 or cortical neurons (i.e. layer IV cortical neurons) of 3-week-old B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice (Figure 4—figure supplement 1B and C). Together, these results demonstrate that changes in mTOR signaling may occur in a celltype-specific manner in the brains of B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice.

Figure 4 with 2 supplements see all
Download asset Open asset
Decreased mTOR signaling enhances neurodegeneration in trGTPase-deficient mice.

(A) Immunofluorescence of P21 hippocampal sections with antibodies against p-S6S240/244 (orange) and S6 (green). Sections were counterstained with DAPI (blue). Higher magnifications of CA1 and dentate gyrus (DG) are shown (n = 3 mice/genotype). (B) Sagittal cerebellar sections of P28 mice injected with vehicle or rapamycin for 14 days stained with hematoxylin and eosin (n = 3 mice/genotype). Higher magnification images of lobule IX are shown below each genotype. Cerebellar lobes are indicated by Roman numerals. (C) Quantification of cerebellar granule cells in lobule VI and lobule IX of either vehicle (V) or rapamycin (R) treated control (B6J), BP1 (B6J.Gtpbp1-/-), and BP2 (B6J-Gtpbp2-/-) mice (n = 3 mice/genotype). Data represent mean + SD. Scale bars: 100 μm and 50 μm (higher magnification) (A); 500 μm and 50 μm (higher magnification) (B). Two-way ANOVA was corrected for multiple comparisons using Tukey method (C). **p≤0.01, ***p≤0.001, ****p≤0.0001.

Figure 4—source data 1

Decreased mTOR signaling enhances neurodegeneration in trGTPase-deficient mice.

https://cdn.elifesciences.org/articles/62731/elife-62731-fig4-data1-v2.xlsx

The decrease in translation initiation by inhibition of the mTOR pathway has been suggested to reduce ribosome pausing during amino acid deprivation (Darnell et al., 2018) suggesting that like the ISR, this pathway may also be protective in the Gtpbp1 and Gtpbp2 mutant brain. However, changes in levels of p-S6240/244 in the mutant hippocampus suggested that decreases in mTOR activity were most profound in hippocampal neurons that ultimately degenerate (i.e. the granule cells of the DG). Thus, to determine the role of mTOR signaling on neuron survival during ribosome pausing, we pharmacologically inhibited mTOR by treating B6J, B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice with rapamycin daily for two weeks beginning at P14. Similar to the dramatic decrease in p-S6240/244 in 3-week-old hippocampi in B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice, cerebellar levels of p-S6240/244 were decreased by approximately 85% by P21 in rapamycin-treated mice (Figure 4—figure supplement 1D–F). Examination of the cerebellum from P28 B6J.Gtpbp1-/- and B6J-Gtpbp2-/- cerebellum revealed that rapamycin treatment increased granule cell loss by 30% (lobule VI) and 40% (lobule IX) compared to mutant mice treated with vehicle (Figure 4B and C). No neuron loss was observed in rapamycin-treated control (B6J) mice (Figure 4B and C). Although it has been reported that mTOR inhibition may cause repression of Atf4 transcripts and some of its target genes (Park et al., 2017), no significant reduction of Atf4 or its targets was observed in rapamycin-treated mutant mice, suggesting that the ISR and mTOR pathways function independently upon loss of Gtpbp1 and Gtpbp2 in the B6J cerebellum (Figure 4—figure supplement 1G).

Rapamycin treatment also increased apoptosis of layer IV cortical neurons by about 3-fold in P28 B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice but did not cause death of other cortical neurons (Figure 4—figure supplement 2A and B). In addition, death of granule cells in the DG was accelerated upon rapamycin treatment. Pyknotic nuclei were observed in 22% of these neurons in P28 rapamycin-treated B6J.Gtpbp1-/- or B6J-Gtpbp2-/- mice, whereas only 3.4% of these neurons had pyknotic nuclei in vehicle-treated mutant mice (Figure 4—figure supplement 2C and D). In addition, the number of granule cells was decreased by 35% in the DG of rapamycin-treated mice, indicating that apoptosis in this region of the brain began earlier (Figure 4—figure supplement 2E). Finally, apoptosis of CA1 neurons was not observed in rapamycin-treated B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice at P28 when treatment began at P14. However, pyknotic nuclei were observed when mice were treated from P28-P42, suggesting that while these neurons are sensitive to mTOR suppression, the timing of this sensitivity differs from that of other neurons (Figure 4—figure supplement 2F). Taken together, our data demonstrate that unlike the ISR, which acts to prevent loss of neurons with ribosome stalling, inhibition of mTOR increases the vulnerability of multiple neuronal populations.

Discussion

Ribosome speed during translation is regulated to allow proper folding of the nascent peptide and functional protein production. However, prolonged pausing or stalling of translating ribosomes can be detrimental to cells. Thus cells have evolved multiple quality control mechanisms that mediate steps from recognition of stalled ribosomes to the resolution of these complexes (Brandman and Hegde, 2016; Joazeiro, 2019). We previously identified GTPBP2 as a ribosome-rescue factor essential for neuronal survival during tRNA deficiency (Ishimura et al., 2014). The high homology of GTPBP1 and GTPBP2, their broad expression patterns, and the lack of overt phenotypes of Gtpbp1-/- mice on a mixed genetic background had suggested functional redundancy of these translational GTPases (Senju et al., 2000). However, we show here that loss of Gtpbp1 leads to widespread neurodegeneration in B6J mice. As observed in Gtpbp2-/- mice, neuron loss in Gtpbp1-/- mice is dependent on a mutation in the B6J strain that disrupts n-Tr20 tRNAArgUCU processing (Ishimura et al., 2014). Ribosome profiling of the Gtpbp1-/- cerebellum revealed increased ribosome occupancy at AGA codons as we previously observed for Gtpbp2-/- mice (Ishimura et al., 2014). These data suggest that both GTPBP1 and GTPBP2 function as ribosome-rescue factors and are essential genes in many neurons when n-Tr20 levels are diminished. In addition, the lack of neurodegeneration in mice heterozygous for mutations in both Gtpbp1 and Gtpbp2 and the lack of an additive phenotype in the brains of mice lacking both genes suggest that these trGTPases function in the same pathway to mitigate ribosome stalling, perhaps mediating different steps in this pathway.

GTPBP1 and GTPBP2 share domain homology with other trGTPases including the yeast protein Hbs1 (HBS1L in mammals) (Atkinson, 2015). Hbs1 and its interacting partner Dom34 recognize paused ribosomes at the 3’end of truncated mRNAs and in the 3’UTR of mRNAs, and the resolution of paused ribosomes is in part gated by the GTPase activity of Hbs1 (Becker et al., 2012; Guydosh et al., 2017; Guydosh and Green, 2014; Juszkiewicz et al., 2020; Pisareva et al., 2011; Shoemaker and Green, 2011). The mechanism by which GTPBP1 and GTPBP2 mitigate defects in ribosome elongation is unknown. Recent biochemical studies revealed that the GTPase activity of GTPBP1 and GTPBP2 is not stimulated in the presence of 80S ribosomes (Zinoviev et al., 2018), suggesting that these two trGTPases likely function differently than Hbs1. In agreement, Dom34/Hbs1 did not mediate pause resolution in a codon-specific manner when pausing was induced at His codons upon inhibition of histidine biosynthesis (Guydosh and Green, 2014).

During the process of pause resolution, multiple factors are recruited to mediate ribosome recycling and degradation of the nascent peptide chains or mRNAs associated with stalled ribosomes (Collart and Weiss, 2020; D'Orazio et al., 2019; Ibrahim et al., 2018; Pelechano et al., 2015). Interestingly, GTPBP1 can stimulate exosomal degradation of mRNAs (Woo et al., 2011), unlike GTPBP2 (Zinoviev et al., 2018), and thus may provide a link between elongation defects and mRNA degradation. Although we did not observe a strong correlation between mRNA abundance and ribosome pausing in the Gtpbp1-/- cerebellum, the stochastic nature of ribosome stalling could make it difficult to observe the corresponding, and similarly stochastic, changes in mRNA decay. RNA-sequencing techniques that are specifically designed to capture degradation intermediates may be more effective in investigating mRNA degradation in vivo (Ibrahim et al., 2018).

As we previously observed in the B6J-Gtpbp2-/- cerebellum (Ishimura et al., 2016), loss of Gtpbp1 induced the ISR via activation of GCN2, and deletion of Gcn2 in B6J.Gtpbp1-/- mice resulted in accelerated, and more widespread, neurodegeneration. GCN2 can be activated by uncharged tRNA that accumulates during amino acid deprivation (Masson, 2019). However, increases in uncharged tRNA were not observed in the B6J-Gtpbp2-/- cerebellum, suggesting other mechanisms underlie GCN2 activation (Ishimura et al., 2016). Indeed, recent biochemical and genetic studies revealed that the P-stalk, a pentameric complex located near the A-site of the ribosome, interacts with GCN2 and activates it, suggesting that translation elongation defects may be sensed directly by GCN2 (Harding et al., 2019; Inglis et al., 2019). Activation of the ISR and its accompanying protective function were observed across multiple neuronal populations in Gtpbp1-/- and Gtpbp2-/- mice. Interestingly, expression of some ATF4 target genes varied between types of neurons, suggesting that additional cell type-specific mechanisms, such as those controlling formation of ATF4 heterodimers, post-translational modifications of ATF4, or epigenetic regulation of target genes may modulate expression of these genes (Wortel et al., 2017).

We also show that defects in ribosome pause resolution in the B6J.Gtpbp1-/- and B6J-Gtpbp2-/- brain are associated with decreased mTORC1 signaling. In contrast to ISR activation, which prolonged neuronal survival, inhibition of mTOR signaling negatively affected neuronal survival in mutant mice, despite the fact that the observed changes in both of these pathways are associated with decreased translation initiation. Previous studies showed that during amino acid starvation of HEK293T cells, reduction of mTOR activity and translation correlated with a reduction in ribosome pausing (Darnell et al., 2018). While inhibition of mTORC1 may be beneficial at the level of translation in some instances of ribosome stress, the negative impact we observe on neuronal survival may reside in the severity or the duration of the stressor and/or the influence of mTORC1 on other cellular processes including ribosomal RNA processing, gene transcription, protein degradation, and ribosomal and mitochondrial biogenesis (Laplante and Sabatini, 2013; Laplante and Sabatini, 2009; López KG de la, 2019; Mayer and Grummt, 2006; Puertollano, 2014).

The dramatic downregulation of mTORC1 activity in granule cells of the B6J.Gtpbp1-/- and B6J-Gtpbp2-/- DG relative to other neurons suggests that the cellular context plays a role in modulating this signaling pathway upon ribosomal stress. A previous study observed increased mTOR activity in epidermal stem cells upon loss of the ribosome recycling factor Pelo, and suppression of mTOR signaling partially restored cellular defects in vivo (Liakath-Ali et al., 2018). We recently observed that the relatively low levels of ribosome pausing that occur upon tRNA deficiency (with normal levels of GTPBP1 and GTPBP2) can lead to mTORC1 inhibition and alter neuronal physiology (Kapur et al., 2020). Together, these data demonstrate that elongation defects may lead to hyper- or hypoactivity of mTOR signaling and these changes in mTORC1 appear to negatively modulate cellular homeostasis and survival.

Whether mTORC1 responds directly to translational stress or alterations in this signaling pathway are due to changes in cellular homeostasis (e.g. amino acid metabolism, energy levels, or neuronal activity) is unknown, as is the mechanism underlying its cell type-specific response. Proteomic experiments have revealed mTOR-dependent phosphorylation of translation initiation factors and ribosomal proteins. Interestingly, multiple phosphorylation sites were observed on the surface of the 80S ribosome, suggesting that mTOR or mTOR-associated kinases can access the ribosome (Jiang et al., 2016). The interaction of mTOR and/or its downstream kinases with the ribosome may provide a mechanism for mTOR to simultaneously monitor and regulate translation. Because protein synthesis varies between cell types and changes during development (Blair et al., 2017; Buszczak et al., 2014; Castelo-Szekely et al., 2017; Gonzalez et al., 2014; Sudmant et al., 2018), the rate of translation may differentially impact elongation defects and thus the signaling pathways which control translation.

Materials and methods

Key resources table
Reagent type
(species) or resource		DesignationSource or referenceIdentifiersAdditional information
Strain, strain background (mouse)Gtpbp1 < tm1Ynim/tm1Ynim>Senju et al., 2000RRID:MGI:3036546Gtpbp1-/- strain (mixed genetic background)
Strain, strain background (mouse)B6J.Gtpbp1<tm1Ynim/tm1Ynim>This studyMGI:6467940B6J.Gtpbp1-/- strain (congenic background, C57BL/6J)
Strain, strain background (mouse)B6J-Gtpbp2-/-(C57BL/6J-Gtpbp2nmf205/J)Ishimura et al., 2014RRID:IMSR_JAX:004823
Strain, strain background (mouse)B6J.Gcn2-/-(B6.129S6-Eif2ak4tm1.2Dron)The Jackson LaboratoryRRID:IMSR_JAX:008240
Sequence-based reagentGenotyping wild type allele Gtpbp1This studyN/AForward Primer: 5’GAGTACGGGCTGAGTGAAGC3’; Reverse Primer:5’TGGACAGGAACCTGATGTGA3’
Sequence-based reagentGenotyping mutant allele Gtpbp1This studyN/AForward Primer: 5’TACGCCACCGTGAAGAGCAT3’; Reverse Primer:5’AGGGGAGGAGTGGAAGGTGG3’
Sequence-based reagentQuantitative RT-PCR (beta actin)This studyN/AForward Primer: 5’GGCTGTATTCCCCTCCATCG3’; Reverse Primer:5’ CCAGTTGGTAACAATGCCATGT3’
Sequence-based reagentRNAscope probe Gtpbp2 (mouse)Advanced Cell Diagnostics#527461
Sequence-based reagentRNAscope probe Gtpbp1 (mouse)Advanced Cell Diagnostics#527451-C3
Sequence-based reagentRNAscope probe Sesn2 (mouse)Advanced Cell DiagnosticsProbe (reference number: 574751-C2) was modified for this study to be compatible with manual RNAscope protocol but is otherwise equivalent to #574758-C2
Sequence-based reagentRNAscope probe Slc7a1 (mouse)Advanced Cell Diagnostics#461021
Sequence-based reagentRNAscope probe Ddr2 (mouse)Advanced Cell Diagnostics#405991-C2
Sequence-based reagentRNAscope probe Chac1 (mouse)Advanced Cell Diagnostics#514501
Commercial assay or kitRNAscope Multiplex Fluorescent Reagent Kit v2Advanced Cell Diagnostics#323100
Commercial assay or kitTSA Plus Cyanine 5PerkinElmerNEL745001KT(1:1000)
Commercial assay or kitTSA Plus Cyanine 3PerkinElmerNEL744001KT(1:2000)
Commercial assay or kitDNA-free DNA Removal KitLife TechnologiesAM1906
Commercial assay or kitSuperScript III First-Strand Synthesis SystemInvitrogen#18080051
Commercial assay or kitiQ SYBR Green SupermixBio-Rad#1708880
Commercial assay or kitTruSeq v2 mRNA kitIlluminaRS-122–2001
Chemical compound, drugRapamycinLC LaboratoriesR5000
AntibodyRabbit anti-phospho-EIF2alpha (polyclonal)Cell Signaling TechnologyCST #9721; RRID:AB_330951WB (1:1000)
AntibodyRabbit anti- EIF2alpha (polyclonal)Cell Signaling
Technology		CST #9722; RRID:AB_2230924WB (1:2000)
AntibodyRabbit anti-phospho S6 ribosomal protein, S240/244(polyclonal)Cell Signaling TechnologyCST #5364; RRID:AB_10694233WB (1:4000)
IF (1:1000)
AntibodyMouse anti-S6 ribosomal protein (monoclonal)Santa Cruz Biotechnologysc-74459; RRID:AB_1129205WB (1:2000)
IF (1:500)
AntibodyMouse anti-Vinculin (monoclonal)SigmaV9131; RRID:AB_477629WB (1:20000)
Software, algorithmGraphPad Prism 7GraphPad softwareRRID:SCR_002798
Software, algorithmkallisto v0.42.4Bray et al., 2016RRID:SCR_016582; https://pachterlab.github.io/kallisto/about
Software, algorithmsleuth v0.30.0Pimentel et al., 2017RRID:SCR_016883; https://pachterlab.github.io/sleuth/about
Software, algorithmfeatureCountsLiao et al., 2014RRID:SCR_012919; http://bioinf.wehi.edu.au/featureCounts
Software, algorithmhisat2 v2.1.0Kim et al., 2019RRID:SCR_015530; https://daehwankimlab.github.io/hisat2/
Software, algorithmfastx_clipperHannon Labhttp://hannonlab.cshl.edu/fastx_toolkit/
Software, algorithmfastx_trimmerHannon Labhttp://hannonlab.cshl.edu/fastx_toolkit/
Software, algorithmbowtie2 v 2.2.3Langmead and Salzberg, 2012RRID:SCR_005476; http://bowtie-bio.sourceforge.net/bowtie2/index.shtml
Software, algorithmRiboWaltz v1.0.1Lauria et al., 2018RRID:SCR_016948; https://github.com/LabTranslationalArchitectomics/RiboWaltz
Software, algorithmDESeq2 v1.22.2Love et al., 2014RRID:SCR_015687; https://bioconductor.org/packages/release/bioc/html/DESeq2.html
Software, algorithmriborex v2.3.4Li et al., 2017RRID:SCR_019104; https://github.com/smithlabcode/riborex
Software, algorithmensembldb v2.6.8Rainer et al., 2019RRID:SCR_019103; https://www.bioconductor.org/packages/release/bioc/html/ensembldb.html
Software,
algorithm		Pause site identification algorithmIshimura et al., 2014N/A
Software, algorithmIngenuity Pathway Analysis (IPA)QIAGEN, IncRRID:SCR_008653; https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis
Software, algorithmDAVID bioinformatics web serverHuang et al., 2009RRID:SCR_001881; http://david.abcc.ncifcrf.gov

Mouse strains

Request a detailed protocol

Gtpbp1-/+ mice were generated previously on a mixed genetic background with a portion of exon three and all of exon four replaced with a PGK-Neo cassette (Senju et al., 2000). These mice were backcrossed to C57BL/6J mice for more than 10 generations to generate congenic B6J.Gtpbp1-/- mice and genotyped with the following primers (wild-type forward primer: 5’GAGTACGGGCTGAGTGAAGC3’, wild type reverse primer: 5’TGGACAGGAACCTGATGTGA3’, mutant forward primer: 5’TACGCCACCGTGAAGAGCAT3’, mutant reverse primer: 5’AGGGGAGGAGTGGAAGGTGG3’). Homozygosity for the tRNA (n-Tr20J/J) mutation was confirmed by genotyping (Ishimura et al., 2014). For transgene rescue experiments, B6J.Tg(n-Tr20wt); Gtpbp1-/- mice were generated by crossing B6J.Gtpbp1+/- mice to B6J-Tg(n-Tr20wt) mice that transgenically express wild-type levels of wild type n-Tr20 (Ishimura et al., 2014) and then backcrossing to B6J.Gtpbp1-/+ mice. C57BL/6J (B6J) and B6J.Gcn2-/- (Eif2ak4tm1.2Dron) mice were obtained from The Jackson Laboratory. Neurological defects were observed in B6J.Gtpbp1-/- and B6J-Gtpbp2-/ males and females; therefore, mice of both sexes were used for experiments. The Jackson Laboratory Animal Care and Use Committee and the University of California San Diego Animal Care and Use Committee approved all mouse protocols (animal protocol number S15286).

Rapamycin treatment

Request a detailed protocol

Rapamycin (LC laboratories) stock solution (50 mg/ml) was prepared in ethanol and diluted on the day of injection in equal volumes of a 10% PEG-400/8% ethanol solution and 10% Tween-80. Mice were injected intraperitoneally with 5 mg/kg rapamycin or vehicle daily; injections were performed from P14-P21 for tissue collection (RNA isolation or western blotting) or from P14-P28 or P28-P42 for histological analysis.

Histology and immunohistochemistry

Request a detailed protocol

Anesthetized mice were transcardially perfused with 4% paraformaldehyde (PFA) for immunofluorescence, 10% neutral buffered formalin (NBF) for in situ hybridization or immunofluorescence, or Bouin’s fixative for histology. Tissues were post-fixed overnight and embedded in paraffin. For histological analysis, sections were deparaffinized, rehydrated, and were stained with hematoxylin and eosin according to standard procedures. Histological slides were imaged using a digital slide scanner (Hamamatsu).

For quantification of cerebellar granule cells, the total number of granule cells (viable and pyknotic cells) were counted in a 0.025 mm2 area from lobule VI or IX and averaged from three sections per brain spaced 100 μm apart at midline. For quantification of hippocampal neurons, the number of neurons with, and without, pyknotic nuclei were counted in the CA1 or DG of the hippocampus and averaged from three sections, spaced 50–70 μm apart and about 1.5 mm off midline, per brain. For quantification of pyknotic nuclei in the cortex, the total number of pyknotic nuclei were counted across the entire section and averaged from three sections per animal spaced 50–70 μm apart and about 2–2.5 mm off midline. All histological quantifications were performed with three mice of each genotype and time point using mice of both sexes.

For immunofluorescence, antigen retrieval on deparaffinized PFA-fixed sections was performed by microwaving sections in 0.01M sodium citrate buffer (pH 6.0, 0.05% Tween-20), three times for three minutes each. NBF-fixed sections were microwaved three times for three minutes, followed by two times for nine minutes. PFA- or NBF-fixed sections were incubated with the following primary antibodies: rabbit anti-cleaved caspase 3-D175 (Cell Signaling, #9661, 1:100, PFA-fixed tissue), CTIP2/BCL11B (Abcam, ab18465, 1:500, PFA-fixed tissue), p-S6240/244 (Cell Signaling, #5364, 1:1000, NBF-fixed tissue), and RPS6 (Santa Cruz Biotechnology, sc-74459, 1:500, NBF-fixed tissue). Detection of primary antibodies was performed with goat anti-mouse Alexa Fluor-488, goat anti-rabbit Alexa Fluor-488, goat anti-rat Alexa Fluor-555, and goat anti-rabbit Alexa Fluor-555 secondary antibodies (Invitrogen). Sections were counterstained with DAPI, and treated with Sudan black to quench autofluorescence.

RNAscope (in situ hybridization)

Request a detailed protocol

In situ hybridization of Gtpbp1, Gtpbp2, Sesn2, Slc7a1, Ddr2 and Chac1 probes was performed as per the manufacturer’s protocol (RNAscope Multiplex Fluorescent Reagent Kit v2; Advanced Cell Diagnostics). Briefly, deparaffinized NBF-fixed sections were treated for 15 min with Target Retrieval Reagent at 100 °C and subsequently treated with Protease Plus for 30 min at 40 °C. RNAscope probes were hybridized for 2 hr. TSA Plus Cyanine 5 (PerkinElmer, 1:1000) was used as a secondary fluorophore for C1 probes (Gtpbp2, Slc7a1, Chac1) and TSA Plus Cyanine 3 (PerkinElmer, 1:2000) was used as a secondary fluorophore for C2 probes (Gtpbp1, Sesn2, Ddr2).

Reverse transcription, quantitative PCR, and genomic PCR analysis

Request a detailed protocol

Cerebella or hippocampi were isolated and immediately frozen in liquid nitrogen. Total RNA was extracted with Trizol reagent (Life Technologies). cDNA synthesis was performed on DNase-treated (DNA-free DNA Removal Kit, Life Technologies AM1906) total RNA using oligo(dT) primers and the SuperScript III First-Strand Synthesis System (Life Technologies). Quantitative RT-PCR (qRT) reactions were performed using iQ SYBR Green Supermix (Bio-Rad) and a CFX96 Real-Time PCR Detection System (Bio-Rad). Reactions were performed with primers previously published (Ishimura et al., 2016). Expression levels of the genes of interest were normalized to β-actin (Actb) (forward primer: 5’GGCTGTATTCCCCTCCATCG3’, reverse primer: 5’ CCAGTTGGTAACAATGCCATGT3’) using the 2-ΔΔCT method (Livak and Schmittgen, 2001) and expressed as fold change + standard error of the mean (SEM) relative to control (B6J).

RNA-Seq library preparation

Request a detailed protocol

Cerebella from various strains were isolated from 3-week-old mice (P21, n = 3 mice for each genotype) and immediately frozen in liquid nitrogen. RNA-Seq libraries were prepared using the TruSeq v2 mRNA kit (Illumina). Briefly, total cerebellar RNA was isolated and RNA quality was assessed on an Agilent TapeStation. mRNA was purified using biotin-tagged poly(dT) oligonucleotides and streptavidin-coated magnetic beads. After fragmentation of mRNA, libraries were prepared according to the manufacturer’s instructions. Paired end reads (2 × 100 bp) were obtained using the HiSeq 4000 (Illumina).

Ribosome profiling library construction

Request a detailed protocol

Ribosome profiling libraries were generated as previously described (Ingolia et al., 2012; Ishimura et al., 2014) with some minor modifications. Briefly, dissected cerebella were immediately frozen in liquid nitrogen. One cerebellum from P21 mice was used for each biological replicate, and three biological replicates were prepared for each genotype. Tissue homogenization was performed with a mixer mill (Retsch MM400) in 350 µl lysis buffer (20 mM Tris-Cl, pH 8.0, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 100 µg/ml CHX, 1% (v/v) TritonX-100, 25 units/ml Turbo DNaseI). Lysates were treated with RNase I and overlaid on top of a sucrose cushion in 5 ml Beckman Ultraclear tubes and centrifuged in an SW55Ti rotor for 4 hr at 4°C at 46,700 rpm. Pellets were resuspended and RNA was extracted using the miRNeasy kit (QIAGEN) according to the manufacturer’s instructions. 26–34 nucleotide RNA fragments were purified by electrophoresis on a 15% denaturing polyacrylamide gel. Linker addition, cDNA generation (first-strand synthesis was performed at 50°C for 1 hr), circularization, rRNA depletion, and amplification of cDNAs with indexing primers were performed. Library quality and concentration were assessed using High Sensitivity D1000 ScreenTapes on the Agilent TapeStation, Qubit 2.0 Fluorometer, and qPCR. Libraries were run on a HiSeq4000 (SR75).

RNA-Seq data analysis

Request a detailed protocol

Reads were quantified using kallisto version 0.42.4 (Bray et al., 2016) and pseudo-aligned to a Gencode M20 transcriptome reference with parameters –bias and -b 100. Differential expression was performed using sleuth version 0.30.0 (Pimentel et al., 2017). To identify differentially expressed genes the following pairwise comparisons were performed: B6J vs. B6J.Gtpbp1-/-, B6J vs. B6J-Gtpbp2-/-, and B6J.Gtpbp1-/- vs. B6J-Gtpbp2-/-. Using functions within sleuth, we aggregated transcript expression at the gene level (by Ensembl gene identifier), fit null models and models corresponding to the genotype of the samples for each gene, and performed Wald tests on the models for each gene to identify differentially expressed genes. Multiple hypothesis testing correction was done using a Benjamini-Hochberg correction, which is the default method in sleuth and referred to as q-value. For downstream TE analysis, mapping to mm10 using a Gencode M20 transcript annotation was performed using hisat2 version 2.1.0 (Kim et al., 2019) using default parameters.

Ribosome profiling data analysis

Request a detailed protocol

Reads were clipped to remove adaptor sequences (CTGTAGGCACCATCAAT) using fastx_clipper and trimmed so that reads start on the second base using fastx_trimmer (http://hannonlab.cshl.edu/fastx_toolkit/). Reads containing ribosomal RNA were then filtered out by mapping to a ribosomal RNA reference using bowtie2 version 2.2.3 using parameters -L 13 (Langmead and Salzberg, 2012). Remaining reads were mapped to a mm10 mouse reference using a Gencode M20 annotation, or a Gencode M20 transcript reference using hisat2 version 2.1.0 (Kim et al., 2019). Ribosomal A-sites were identified using RiboWaltz version 1.0.1 (Lauria et al., 2018), and read lengths 29–33 were retained for further analysis. Observed/expected reads were calculated with the expected reads being the read density expected at a given site with a given codon, assuming that reads are uniformly distributed across the coding part of the transcript. Pauses were identified using previous methodology (Ishimura et al., 2014) using a 0.5 reads/codon in all samples to threshold transcripts to analyze. Correlation between gene pauses and gene expression was calculated by taking the average pause scores of transcripts associated with a gene for transcripts with ≥0.5 reads/codon across the B6J.Gtpbp1-/- samples. The sum of these pause scores across all replicates was then correlated with the sleuth beta values (in the B6J.Gtpbp1-/- vs. B6J comparison) for genes that passed the reads/codon thresholding in the ribosome profiling datasets.

Read counts for translational efficiency (TE) analysis were quantified using featureCounts (Liao et al., 2014) with footprints overlapping CDS features and RNA read pairs overlapping gene exon features. Histone mRNAs were removed from the analysis by removing gene names with the prefix ‘Hist’ and filtering out genes in HistoneDB 2.0 (Draizen et al., 2016). Differential TE analysis was performed using riborex version 2.3.4 using the DESeq2 engine (Li et al., 2017). TE analysis of AGA A-site filtered datasets was performed by identifying AGA codons in the transcriptome and transferring the coordinates to the genome using ensembldb v.2.6.8 (Rainer et al., 2019). Then reads with AGAs in the A-site (±1 codon based on riboWaltz A-site offset for each read length) were removed and the above TE analysis was performed. A list of mouse genes with known TOP motifs were identified in Yamashita et al., 2008.

Gene ontology (GO) and pathway analysis

Request a detailed protocol

RNA-sequencing data were analyzed using Ingenuity Pathway Analysis (QIAGEN Inc, https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis). Gene Ontology (GO) pathway analysis was performed using the DAVID bioinformatics web server (http://david.abcc.ncifcrf.gov) by uploading the gene lists from our ribosome profiling analysis (AGA pausing genes, z ≥ 10, stalls detected in any biological replicates). The functional annotation chart and clustering analysis modules were utilized for gene-term enrichment analysis, and terms with a Benjamini-Hochberg adjusted p-value≤0.05 were considered enriched.

Western blotting

Request a detailed protocol

Cerebella or hippocampi were isolated and immediately frozen in liquid nitrogen. Proteins were extracted by homogenizing tissue in 5 volumes of RIPA buffer with cOmplete Mini, EDTA-free Protease Inhibitor Cocktail (Roche), sonicated two times for 10 s (Branson, 35% amplitude), incubated for 30 min at 4°C, centrifuged at 16,000xg for 25 min, and 25 µg of whole protein lysate were resolved on SDS-PAGE gels prior to transfer to PVDF membranes (GE Healthcare Life Sciences, #10600023) using a tank blotting apparatus (BioRad).

For detection of phosphoproteins, frozen tissue samples were homogenized in 5 volumes of homogenization buffer (50 mM HEPES/KOH, pH 7.5, 140 mM potassium acetate, 4 mM magnesium acetate, 2.5 mM dithiothreitol, 0.32M sucrose, 1 mM EDTA, 2 mM EGTA) (Carnevalli et al., 2004), supplemented with phosphatase and protease inhibitors (PhosStop and cOmplete Mini, EDTA-free Protease Inhibitor Cocktail, Roche). Lysate samples were centrifuged at 12,000xg for 7 min, and either 30 µg (detection of ribosomal protein S6) or 70 µg (detection of eIF2alpha) of whole protein lysate were resolved on SDS-PAGE gels prior to transfer to PVDF membranes. After blocking in 5% nonfat dry milk (Cell Signaling, #9999S), blots were probed with primary antibodies at 4°C overnight: rabbit anti-phospho-S6240/244 (Cell Signaling, #5364, 1:4000), mouse anti-RPS6 (Santa Cruz Biotechnology, sc-74459, 1:2000), rabbit anti-phospho-eIF2alphaS51 (Cell Signaling, #9721, 1:1000), rabbit anti-eIF2alpha (Cell Signaling, #9722, 1:2000), mouse anti-vinculin (Sigma, V-9131, 1:20,000). Followed by incubation with HRP-conjugated secondary antibodies for 2 hr at room temperature: goat anti-rabbit IgG (BioRad, #170–6515) or goat anti-mouse IgG (BioRad, #170–6516). Signals were detected with SuperSignal West Pico Chemiluminescent Substrate (ThermoScientific, #34080).

Statistics

For quantification of protein expression, RNA expression, or histological quantifications, p-values were computed in GraphPad Prism using either multiple t-tests, one-way ANOVA, or two-way ANOVA, and corrected for multiple comparisons as indicated in the figure legends. All quantifications were performed with at least three mice of each genotype and time point. Neurological defects were observed in B6J.Gtpbp1-/- and B6J-Gtpbp2-/- male and female mice. Therefore, mice of both sexes were used for experiments.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. The RNA sequencing and ribosome footprint data have been made available (GSE157902).

The following data sets were generated

References

Decision letter

  1. David Ron
    Reviewing Editor; University of Cambridge, United Kingdom
  2. Huda Y Zoghbi
    Senior Editor; Texas Children's Hospital, United States
  3. David Ron
    Reviewer; University of Cambridge, United Kingdom
  4. Nahum Sonenberg
    Reviewer; McGill University, Canada

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Thank you for submitting your article "GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis" for consideration by eLife. Your article has been reviewed by three peer reviewers, including David Ron as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Huda Zoghbi as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Nahum Sonenberg (Reviewer #3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This manuscript addresses the functions of translational GTPases in the resolution of stalling of elongating ribosomes and neuronal homeostasis. Prior studies from the same laboratory suggested that GTPBP2 is essential for release of ribosomes stalled at Arg codons; loss of GTPBP2 increased ribosome stalling, activated Gcn2 and the Integrated stress response (ISR), and enhanced neurodegeneration. The present manuscript uses elegant mouse genetic models and associated cell biology and biochemistry to explore similar questions with the related GTPBP1. Key discoveries are that loss of GTPBP1 leads to similar ribosome stalling and degeneration in selected neuronal tissues. Furthermore, loss of GTPBP1 activates GCN2 and loss of this eIF2 kinase accelerates degeneration of brain sections. Importantly, the compound GTPBP1/2 mutant is no more impaired than either single mutation. These results indicate while GTPBP1 and GTPBP2 are highly related they are not redundant, rather they function at different steps in the same pathway. The manuscript shows that there are differences in mTORC1 signaling among the neuronal tissues upon loss of GTPBP1. mTORC1 signaling and the integrated stress response are inversely regulated in response to stress and the loss of GTPBP1 and associated ribosome stalling is linked with lowered mTORC1 in hippocampus, whereas mTORC1 signaling was not altered in granule cells, comprising most of the cerebellum. Therefore, there can be concordant and discordant regulation between the integrated stress response and mTORC1 depending on the neuronal cell types; pharmacological inhibition of mTORC1 upon GTPBP1 depletion enhanced cell death.

Overall, this is a significant and timely study that would be of broad interest. The manuscript provides new insights into resolution of ribosome stalling, associated regulation of stress response pathways, and mechanisms underlying neurodegeneration and supports the surprising conclusion that despite their similarity GTPBP1 and GTPBP2 have different functions in the same pathway. Experiments are rigorous and appropriately interpreted. The manuscript is clearly presented and flows logically. As you will read in the unedited reviews the reviewers initially differed in their assessment of the significance of the findings relating to TOR, but the consensus to emerge was to favour the less critical view of reviewers 2 and 3, on this point.

Essential revisions:

Listed below are the points we find especially important to address in a revised version of the manuscript, that we hope to receive from you in short order.

1) The manuscript features ribosome profiling and RNA-seq that are presented sequentially in the subsection “GTPBP1 is a novel ribosome-rescue factor”. However, which dataset is being analyzed and discussed is not always clear to the reader. It should be clarified whether the profiling was normalized for RNA- translational efficiencies. This normalization point should be clarified in the Results text and the legend for Figure 2. Figure 2D refers to analysis of differential gene expression, a generic term that is used later for the RNA-seq analysis. More precision in the language through the translational efficiency and mRNA levels would be helpful. Furthermore, Figure 3 should clarify whether the "analysis of differential gene expression" refers to mRNA measurements.

2) At several points in the manuscript it is stated that ribosome stalling induces GCN2 and mTORC1 signaling. The evidence for GCN2 induction by ribosome stalling is strong based on research from this lab and others. The idea that ribosome stalling directly induces neuron-specific changes in mTOR signaling warrants some caution (as opposed to indirect regulation through changes in the integrated stress response, amino acid pools, or other mechanisms).

3) GTPBP1 and GTPBP2 are very similar and act by a similar mechanism. It is thus very surprising that only 50% of AGA pausing genes with increased AGA occupancy intersected between B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice (Figure 2—figure supplement 1B, Supplementary file 1). It is even more surprising that the biological processes as defined by Gene Ontology (GO) analysis of pausing genes

revealed enrichment in different biological processes between Gtpbp1 and Gtpbp2 (Figure 2—figure supplement 1C). All this consistent with the finding that GTPBP1 and GTPBP2 are not mechanistically redundant, but the mechanistic insight, although not known should be mentioned and discussed.

4) Figure 1C – It appears that there is much more GTPBP2 than GTPBP1. Is it correct? What is the ratio? Also, the two proteins do not co-localize. Localization is even mutually exclusive. What do these results mean?

5) Figure 3C – why is the amount of S6 and its phosphorylated form reduced in the hippocampus, but not in the cerebellum. Any differences in mTOR or upstream effectors amounts between these two structures?

6) The experimental evidence provided here strongly supports the conclusion that the two GTPBP's function in the same pathway. This might be expected, given the similarity of the encoded proteins but surprisingly, the compound BL6/J GTPBP1∆/∆;GTPBP2∆/∆ is no more compromised than either BL6/J GTPBP1∆/∆ or BL6/J GTPBP2∆/∆ single mutants. This last observation provides genetic evidence that despite considerable similarity in their encoded proteins, the two genes act at different steps in the same pathway. This is a surprising finding that stands to influence thinking in this area and will generate a search for the mechanistic basis of differences in function between GTPBP1 and GTPBP2 and the specific steps they act on in coping with stalled ribosomes (see also point 3, above). Less interesting would be a study that concluded that these two proteins do more or less the same thing and that the gene duplication that gave rise to their presence in the mammalian genome represents some sort of fine tuning, the basis of which remains for now obscure. The critical experiment examining this point is shown in Figure 1F and G, which compare the number of granule cells in two lobes of the cerebellum at a single time point (6 weeks) in three mice each with the relevant genotypes. The equivalence of the loss of cells between the three relevant genotypes (GTPBP1∆/∆;GTPBP2∆/∆, GTPBP1∆/∆ and GTPBP2∆/∆) is impressive and fits well the conclusion that GTPBP1 and GTPBP2 are active on different steps in the same pathway. However, the lack of a temporal component to the measurements, limits the strength of that key conclusion. For example, it is possible that by six weeks of age the histological changes had plateaued, obscuring important differences in the rate at which that plateau had been reached by the different genotypes. If the compound mutants were actually to degenerate more quickly than either single mutant, the paper's key conclusion would be wrong in that it would suggest that the two GTPBP's are in fact redundant and carry out the same step biochemically. Addressing this issue seems key to the significance of this paper.

https://doi.org/10.7554/eLife.62731.sa1

Author response

Essential revisions:

Listed below are the points we find especially important to address in a revised version of the manuscript, that we hope to receive from you in short order.

1) The manuscript features ribosome profiling and RNA-seq that are presented sequentially in the subsection “GTPBP1 is a novel ribosome-rescue factor”. However, which dataset is being analyzed and discussed is not always clear to the reader. It should be clarified whether the profiling was normalized for RNA- translational efficiencies. This normalization point should be clarified in the Results text and the legend for Figure 2. Figure 2D refers to analysis of differential gene expression, a generic term that is used later for the RNA-seq analysis. More precision in the language through the translational efficiency and mRNA levels would be helpful. Furthermore, Figure 3 should clarify whether the "analysis of differential gene expression" refers to mRNA measurements.

We appreciate the input as this may also confuse readers. We have clarified our language to specifically identify the datasets we are referring to. In addition, we defined in the text, legends, and Materials and methods, that translation efficiency (TE) data reflect normalization of the abundance of ribosome-protected fragments to that of RNA-Seq reads and refer to these data more consistently as TE Gtpbp1 or TE Gtpbp2. Our RNA-Seq data were utilized to measure mRNA abundance and we now refer to changes in mRNA abundance as transcriptional differences in gene expression (DE Gtpbp1 or DE Gtpbp2) in the text and in the legend for Figure 3.

2) At several points in the manuscript it is stated that ribosome stalling induces GCN2 and mTORC1 signaling. The evidence for GCN2 induction by ribosome stalling is strong based on research from this lab and others. The idea that ribosome stalling directly induces neuron-specific changes in mTOR signaling warrants some caution (as opposed to indirect regulation through changes in the integrated stress response, amino acid pools, or other mechanisms).

We agree with the reviewer and did not mean to imply that changes in mTOR signaling are a direct result of ribosome stalling. We have included a statement in the Discussion to this effect.

3) GTPBP1 and GTPBP2 are very similar and act by a similar mechanism. It is thus very surprising that only 50% of AGA pausing genes with increased AGA occupancy intersected between B6J.Gtpbp1-/- and B6J-Gtpbp2-/- mice (Figure 2—figure supplement 1B, Supplementary file 1). It is even more surprising that the biological processes as defined by Gene Ontology (GO) analysis of pausing genes

revealed enrichment in different biological processes between Gtpbp1 and Gtpbp2 (Figure 2—figure supplement 1C).

Pausing on AGA codons is very robust in the Gtpbp1-/- cerebellum as shown in Figure 2 A and B, and is consistent with our previous data from the Gtpbp2-/- cerebellum. However, the genes with pause sites in each biological replicate for either genotype only overlap by about 50% (Figure 2C). This suggests that ribosome pausing is stochastic, i.e., it can occur at any AGA codon in any gene, but doesn’t occur at all codons at a given time. Capturing all stochastic events would require a substantially higher sequencing depth and therefore, we likely only scratched the surface in defining pausing events in these mice. Furthermore, as pointed out in the Results and the Materials and methods, we only considered strong pauses for our analysis (z-score above 10, that is pausing is at least 10 standard deviations above background). Our thresholds are picked to have high confidence in our pausing data. However, weaker pauses may be missed at the expense of high confidence. Thus, all things considered, we wouldn’t expect to observe a higher overlap between two different genotypes.

As we would expect from stochastic pausing, pausing genes are enriched for many GO terms. Most of TOP GO terms (17 out of 24) overlap between Gtpbp1 and Gtpbp2 and the GO terms that appear unique to pauses which occur in a given genotype, are again likely due to the depth of our ribosome profiling datasets. Indeed, to circumvent the limitations of single/individual experiments, our conclusion of Gtpbp1 and Gtpbp2 are likely acting in the same pathway is not just derived from our profiling data, but rather is a collective hypothesis based on both our genomic and genetic data.

All this consistent with the finding that GTPBP1 and GTPBP2 are not mechanistically redundant, but the mechanistic insight, although not known should be mentioned and discussed.

Our study, together with the recent biochemical study from Zinoviev et al., 2018, are the first studies that analyze Gtpbp1 and Gtpbp2 side by side. Thus, we only have limited understanding about the shared or unique functions of these two proteins and we have included a statement in the Discussion to point out that the function of these proteins is still unknown. The biochemical experiments by Zinoviev et al. revealed striking differences in mRNA decay for these two proteins which we have discussed in the Discussion.

4) Figure 1C – It appears that there is much more GTPBP2 than GTPBP1. Is it correct? What is the ratio? Also, the two proteins do not co-localize. Localization is even mutually exclusive. What do these results mean?

Figure 1C shows our in situ hybridization experiments for mRNA as mentioned in the Results and figure legend. Thus, the fluorescent punta do not indicate protein localization, nor does the nature of this experiment (different probes for each gene that are labeled with different fluorophores) allow us to measure levels of Gtpbp1 and Gtpbp2 transcripts. However, these experiments do show that the mRNAs for Gtpbp1 and Gtpbp2 are found in the same neurons and are expressed in both neurons that degenerate and those that do not.

5) Figure 3C – why is the amount of S6 and its phosphorylated form reduced in the hippocampus, but not in the cerebellum. Any differences in mTOR or upstream effectors amounts between these two structures?

We do not know why the mTOR pathway responds to defects in translation in cell type-specific fashion. Both positive and negative regulators of the mTOR pathway (e.g. AKT, ERK, PTEN, TSC1/2, etc.) are ubiquitously expressed (as far as we know) and we detected expression these genes in our transcriptome datasets from the cerebellum. However, proteomics data might be more insightful as many mTOR regulators act at the protein level and/or thru post-translational modifications. Even so to point to differences in upstream effectors that alter mTOR would require systemic genetic and/or molecular studies across different neuronal populations.

A large body of literature has shown that the mTOR pathway can respond to numerous cellular insults and that the activity of this signaling pathway is influenced by changes in cellular homeostasis including protein synthesis, neuronal activity and energy balance. The particular alteration(s) in cellular homeostasis in the Gtpbp1-/- and Gtpbp2-/- brain that triggers a decrease in mTOR activity is unknown, making it even more difficult to speculate about the cell type-specific responses we observed. In the Discussion, we suggest that defects in translation in different cell types lead to differences in the amount and type of perturbations, perhaps due to the differences in basal translation between cells, and this in turn could result in differential homeostatic changes.

6) The experimental evidence provided here strongly supports the conclusion that the two GTPBP's function in the same pathway. This might be expected, given the similarity of the encoded proteins but surprisingly, the compound BL6/J GTPBP1∆/∆;GTPBP2∆/∆ is no more compromised than either BL6/J GTPBP1∆/∆ or BL6/J GTPBP2∆/∆ single mutants. This last observation provides genetic evidence that despite considerable similarity in their encoded proteins, the two genes act at different steps in the same pathway. This is a surprising finding that stands to influence thinking in this area and will generate a search for the mechanistic basis of differences in function between GTPBP1 and GTPBP2 and the specific steps they act on in coping with stalled ribosomes (see also point 3, above). Less interesting would be a study that concluded that these two proteins do more or less the same thing and that the gene duplication that gave rise to their presence in the mammalian genome represents some sort of fine tuning, the basis of which remains for now obscure. The critical experiment examining this point is shown in Figure 1F and G, which compare the number of granule cells in two lobes of the cerebellum at a single time point (6 weeks) in three mice each with the relevant genotypes. The equivalence of the loss of cells between the three relevant genotypes (GTPBP1∆/∆;GTPBP2∆/∆, GTPBP1∆/∆ and GTPBP2∆/∆) is impressive and fits well the conclusion that GTPBP1 and GTPBP2 are active on different steps in the same pathway. However, the lack of a temporal component to the measurements, limits the strength of that key conclusion. For example, it is possible that by six weeks of age the histological changes had plateaued, obscuring important differences in the rate at which that plateau had been reached by the different genotypes. If the compound mutants were actually to degenerate more quickly than either single mutant, the paper's key conclusion would be wrong in that it would suggest that the two GTPBP's are in fact redundant and carry out the same step biochemically. Addressing this issue seems key to the significance of this paper.

We included additional time points (3 and 4 weeks) in Figure 1 for the double mutants. Our data show that onset and progression of granule cell death are very similar between Gtpbp1-/-, Gtpbp2-/-, and Gtpbp1-/-; Gtpbp2-/- cerebella.

https://doi.org/10.7554/eLife.62731.sa2

Article and author information

Author details

  1. Markus Terrey

    1. Howard Hughes Medical Institute, Department of Cellular and Molecular Medicine, Section of Neurobiology, Division of Biological Sciences, University of California, San Diego, San Diego, United States
    2. Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, United States
    Contribution
    Conceptualization, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing, Designed experiments and wrote the paper. Performed experiments using Gcn2-/- mice. Performed mouse and molecular biology experiments under SLA's guidance
    Competing interests
    No competing interests declared

  2. Scott I Adamson

    1. The Jackson Laboratory for Genomic Medicine, Farmington, United States
    2. Department of Genetics and Genome Sciences, Institute for Systems Genomics, UConn Health, Farmington, United States
    Contribution
    Formal analysis, Investigation, Methodology, Writing - review and editing, Performed the computational analysis of RNA-sequencing and ribosome profiling data under JHC's guidance
    Competing interests
    No competing interests declared

  3. Alana L Gibson

    Howard Hughes Medical Institute, Department of Cellular and Molecular Medicine, Section of Neurobiology, Division of Biological Sciences, University of California, San Diego, San Diego, United States
    Contribution
    Investigation, Performed RNAscope and immunofluorescence experiments for ribosomal protein S6
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2247-7064

  4. Tianda Deng

    Division of Biological Sciences, Section of Molecular Biology, University of California, San Diego, San Diego, United States
    Contribution
    Investigation, Performed experiments using Gcn2-/- mice
    Competing interests
    No competing interests declared

  5. Ryuta Ishimura

    The Jackson Laboratory for Mammalian Genetics, Bar Harbor, United States
    Contribution
    Investigation, Performed initial phenotype analysis of Gtpbp1-/- mice
    Competing interests
    No competing interests declared

  6. Jeffrey H Chuang

    The Jackson Laboratory for Genomic Medicine, Farmington, United States
    Contribution
    Supervision, Writing - review and editing
    Competing interests
    No competing interests declared

  7. Susan L Ackerman

    Howard Hughes Medical Institute, Department of Cellular and Molecular Medicine, Section of Neurobiology, Division of Biological Sciences, University of California, San Diego, San Diego, United States
    Contribution
    Conceptualization, Supervision, Funding acquisition, Writing - review and editing, Designed experiments and wrote the paper
    For correspondence
    sackerman@ucsd.edu
    Competing interests
    Is a Reviewing Editor for eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6740-593X

Funding

National Institute of Neurological Disorders and Stroke (NS094637)

  • Susan L Ackerman

Howard Hughes Medical Institute

  • Susan L Ackerman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank T Jucius, and A Kano for technical assistance, Drs. Satori Senju and Yasuharu Mishimura for providing Gtpbp1-/- mice, the IGM Genomics Center at the University of California San Diego (UCSD) for support with the preparation of RNA-sequencing libraries and sequencing, and the UCSD School of Medicine Microcopy Core for providing access to microscopy equipment (Grant P30 NS047101). This work was supported by NIH NS094637 (SLA). SLA is an investigator of the Howard Hughes Medical Institute.

Ethics

Animal experimentation: The Jackson Laboratory Animal Care and Use Committee and the University of California San Diego Animal Care and Use Committee approved all mouse protocols. Animal protocol number S15286.

Senior Editor

  1. Huda Y Zoghbi, Texas Children's Hospital, United States

Reviewing Editor

  1. David Ron, University of Cambridge, United Kingdom

Reviewers

  1. David Ron, University of Cambridge, United Kingdom
  2. Nahum Sonenberg, McGill University, Canada

Publication history

  1. Received: September 3, 2020
  2. Accepted: October 26, 2020
  3. Version of Record published: November 13, 2020 (version 1)
  4. Version of Record updated: June 4, 2021 (version 2)

Copyright

© 2020, Terrey et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,839
    Page views
  • 253
    Downloads
  • 16
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Markus Terrey
  2. Scott I Adamson
  3. Alana L Gibson
  4. Tianda Deng
  5. Ryuta Ishimura
  6. Jeffrey H Chuang
  7. Susan L Ackerman
(2020)
GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis
eLife 9:e62731.
https://doi.org/10.7554/eLife.62731

Categories and tags

Research organism

Further reading

    1. Chromosomes and Gene Expression
    2. Neuroscience

    Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation

    Ryuta Ishimura, Gabor Nagy ... Susan L Ackerman
    Research Article Updated

    Ribosome stalling during translation has recently been shown to cause neurodegeneration, yet the signaling pathways triggered by stalled elongation complexes are unknown. To investigate these pathways we analyzed the brain of C57BL/6J-Gtpbp2nmf205-/- mice in which neuronal elongation complexes are stalled at AGA codons due to deficiencies in a tRNAArgUCU tRNA and GTPBP2, a mammalian ribosome rescue factor. Increased levels of phosphorylation of eIF2α (Ser51) were detected prior to neurodegeneration in these mice and transcriptome analysis demonstrated activation of ATF4, a key transcription factor in the integrated stress response (ISR) pathway. Genetic experiments showed that this pathway was activated by the eIF2α kinase, GCN2, in an apparent deacylated tRNA-independent fashion. Further we found that the ISR attenuates neurodegeneration in C57BL/6J-Gtpbp2nmf205-/- mice, underscoring the importance of cellular and stress context on the outcome of activation of this pathway. These results demonstrate the critical interplay between translation elongation and initiation in regulating neuron survival during cellular stress.

    1. Chromosomes and Gene Expression
    2. Plant Biology

    Vernalization-triggered expression of the antisense transcript COOLAIR is mediated by CBF genes

    Myeongjune Jeon, Goowon Jeong ... Ilha Lee
    Research Article Updated

    To synchronize flowering time with spring, many plants undergo vernalization, a floral-promotion process triggered by exposure to long-term winter cold. In Arabidopsis thaliana, this is achieved through cold-mediated epigenetic silencing of the floral repressor, FLOWERING LOCUS C (FLC). COOLAIR, a cold-induced antisense RNA transcribed from the FLC locus, has been proposed to facilitate FLC silencing. Here, we show that C-repeat (CRT)/dehydration-responsive elements (DREs) at the 3′-end of FLC and CRT/DRE-binding factors (CBFs) are required for cold-mediated expression of COOLAIR. CBFs bind to CRT/DREs at the 3′-end of FLC, both in vitro and in vivo, and CBF levels increase gradually during vernalization. Cold-induced COOLAIR expression is severely impaired in cbfs mutants in which all CBF genes are knocked-out. Conversely, CBF-overexpressing plants show increased COOLAIR levels even at warm temperatures. We show that COOLAIR is induced by CBFs during early stages of vernalization but COOLAIR levels decrease in later phases as FLC chromatin transitions to an inactive state to which CBFs can no longer bind. We also demonstrate that cbfs and FLCΔCOOLAIR mutants exhibit a normal vernalization response despite their inability to activate COOLAIR expression during cold, revealing that COOLAIR is not required for the vernalization process.